Carolyn Robb
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Carolyn Robb has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Martin Keltz
New York Medical College School of Medicine, Valhalla, USA
2 shared publicationsAlexis Greene
New York Medical College School of Medicine, Valhalla, USA
1 shared publicationAnnieka Reno
New York Medical College, Valhalla, New York, USA
1 shared publicationChloe Schreiber
New York Medical College School of Medicine, Valhalla, USA
1 shared publication- Elizabeth D. Drugge
New York Medical College, Valhalla, New York
1 shared publication Elizabeth Drugge
New York Medical College, Valhalla, New York, USA
1 shared publication
Latest Publications
- Open Access
- 8 August 2026
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 411 (1)
A 5-mm open umbilical entry technique for laparoscopic gynecologic surgery
Background and objectives: Laparoscopic entry carries a complication rate of up to 1.3%, including bowel and vascular injury. The Hasson, Veress, and 5-mm open entry techniques differ in approach: Hasson uses a 1–2 cm open incision, Veress involves blind needle access, and the 5-mm open entry technique uses a small umbilical incision with blunt peritoneal entry followed by insertion of a 5-mm bladeless optical trocar. Previously shown to be safe and easily mastered by both attendings and residents, this study re-evaluates the 5-mm technique in a multi-surgeon setting. Methods: The senior author’s extensive clinical experience with this technique informed its continued use and motivated the present retrospective evaluation of all consecutive cases performed between 2021 and 2025. The technique involves tenting the umbilicus with three tonsil clamps, injecting 1 mL of 0.25% bupivacaine, making a 2–4 mm vertical incision within the umbilical scar that is then stretched to approximately 5 mm with a tonsil clamp, and bluntly dissecting the fascia to expose the mid-umbilical fascia and enter the peritoneal cavity. A 5-mm bladeless optical trocar is advanced under direct visualization, and carbon dioxide insufflation begins once placement is confirmed. Results: All cases achieved successful entry without conversion to Veress. One patient had a Hasson entry for concurrent cholecystectomy. Omental adhesions were present in 15 cases (7.7%). No entry-related complications occurred. Conclusion: In this cohort, the 5-mm open entry technique was successfully performed without entry-related complications and demonstrated favorable cosmetic outcomes.
- 8 August 2026
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 411 (1)
Open AccessA 5-mm open umbilical entry technique for laparoscopic gynecologic surgery
Background and objectives: Laparoscopic entry carries a complication rate of up to 1.3%, including bowel and vascular injury. The Hasson, Veress, and 5-mm open entry techniques differ in approach: Hasson uses a 1–2 cm open incision, Veress involves blind needle access, and the 5-mm open entry technique uses a small umbilical incision with blunt peritoneal entry followed by insertion of a 5-mm bladeless optical trocar. Previously shown to be safe and easily mastered by both attendings and residents, this study re-evaluates the 5-mm technique in a multi-surgeon setting. Methods: The senior author’s extensive clinical experience with this technique informed its continued use and motivated the present retrospective evaluation of all consecutive cases performed between 2021 and 2025. The technique involves tenting the umbilicus with three tonsil clamps, injecting 1 mL of 0.25% bupivacaine, making a 2–4 mm vertical incision within the umbilical scar that is then stretched to approximately 5 mm with a tonsil clamp, and bluntly dissecting the fascia to expose the mid-umbilical fascia and enter the peritoneal cavity. A 5-mm bladeless optical trocar is advanced under direct visualization, and carbon dioxide insufflation begins once placement is confirmed. Results: All cases achieved successful entry without conversion to Veress. One patient had a Hasson entry for concurrent cholecystectomy. Omental adhesions were present in 15 cases (7.7%). No entry-related complications occurred. Conclusion: In this cohort, the 5-mm open entry technique was successfully performed without entry-related complications and demonstrated favorable cosmetic outcomes.
- Open Access
- 5 May 2026
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 313 (1)
Severe maternal morbidity in patients of advanced maternal age with and without metabolic syndrome
Purpose: To estimate the burden of metabolic syndrome (MetS) on severe maternal morbidity (SMM) in women of advanced maternal age (AMA), quantify age-related escalation in SMM risk, and evaluate sociodemographic influences. Methods: We retrospectively conducted a cross-sectional, population-level analysis of the Nationwide Inpatient Sample (Q4 2015–2019), a discharge-level database, to identify delivery hospitalizations among patients aged ≥ 35 years. MetS was defined by ICD-10 codes indicating ≥ 3 of the following: hypertension, type 2 diabetes, obesity, hypertriglyceridemia, or low high-density lipoprotein cholesterol. The primary outcome was SMM as defined by the Centers for Disease Control and Prevention; a secondary outcome excluded blood transfusion. Multivariable logistic regression adjusted for race, income quartile, primary payer, hospital characteristics, and substance use. Weighted adjusted odds ratios (AORs) with 95% confidence intervals (CIs) were reported. Results: Among 3.1 million delivery hospitalizations, 556,609 (17.8%) occurred in AMA patients; 12,188 (2.2%) experienced SMM and 6,528 (1.2%) experienced nontransfusion SMM. SMM was significantly higher among patients with MetS compared to those without (7.37% vs 2.17%; nontransfusion SMM: 5.36% vs 1.16%). SMM rates increased with advancing age. After adjustment, MetS was associated with markedly increased odds of SMM (AOR 2.75, 95% CI 2.29–3.30) and nontransfusion SMM (AOR 3.59, 95% CI 2.90–4.44), both p < 0.001. Conclusion: MetS is associated with SMM risk among AMA patients, independent of sociodemographic factors, with risk increasing further at older maternal ages. This study quantifies the disproportionate burden of MetS in this high-risk population.
- 5 May 2026
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 313 (1)
Open AccessSevere maternal morbidity in patients of advanced maternal age with and without metabolic syndrome
Purpose: To estimate the burden of metabolic syndrome (MetS) on severe maternal morbidity (SMM) in women of advanced maternal age (AMA), quantify age-related escalation in SMM risk, and evaluate sociodemographic influences. Methods: We retrospectively conducted a cross-sectional, population-level analysis of the Nationwide Inpatient Sample (Q4 2015–2019), a discharge-level database, to identify delivery hospitalizations among patients aged ≥ 35 years. MetS was defined by ICD-10 codes indicating ≥ 3 of the following: hypertension, type 2 diabetes, obesity, hypertriglyceridemia, or low high-density lipoprotein cholesterol. The primary outcome was SMM as defined by the Centers for Disease Control and Prevention; a secondary outcome excluded blood transfusion. Multivariable logistic regression adjusted for race, income quartile, primary payer, hospital characteristics, and substance use. Weighted adjusted odds ratios (AORs) with 95% confidence intervals (CIs) were reported. Results: Among 3.1 million delivery hospitalizations, 556,609 (17.8%) occurred in AMA patients; 12,188 (2.2%) experienced SMM and 6,528 (1.2%) experienced nontransfusion SMM. SMM was significantly higher among patients with MetS compared to those without (7.37% vs 2.17%; nontransfusion SMM: 5.36% vs 1.16%). SMM rates increased with advancing age. After adjustment, MetS was associated with markedly increased odds of SMM (AOR 2.75, 95% CI 2.29–3.30) and nontransfusion SMM (AOR 3.59, 95% CI 2.90–4.44), both p < 0.001. Conclusion: MetS is associated with SMM risk among AMA patients, independent of sociodemographic factors, with risk increasing further at older maternal ages. This study quantifies the disproportionate burden of MetS in this high-risk population.
- 16 February 2026
- Published by SAGE Publications in Journal of Women's Health
Racial Disparities in Severe Maternal Morbidity Among Patients with Polycystic Ovarian Syndrome
Objective: To evaluate the association between race and severe maternal morbidity (SMM) in delivery hospitalizations with polycystic ovarian syndrome (PCOS). Design: Retrospective cross-sectional study using the Nationwide Inpatient Sample (Q4 2015–2019). SMM was defined by the CDC algorithm of 21 ICD-10 indicators. Multivariable logistic regression assessed associations between race and SMM, adjusting for demographics, insurance, hospital type, obesity, hypertension, and diabetes. Subjects: Delivery hospitalizations with PCOS (ICD-10 E28.2). Results: Of 3.1 million deliveries, 19,962 (0.64%) had PCOS; 444 (2.22%) experienced SMM. Patients were predominantly White (66.7%) and <35 years (76.9%). Common comorbidities included obesity (30.2%), hypertension (9.5%), and diabetes (5.1%). Unadjusted analyses showed the highest SMM among Black (3.4%), Native American/Other (3.0%), and Asian/Pacific Islander (2.7%) patients. SMM was also more common among those ≥35 years, with public insurance, and at urban teaching hospitals. In adjusted models, Native American/Other (adjusted odds ratio [AOR] 1.44, 95% confidence interval [CI] 1.07–1.92), Black (AOR 1.42, 95% CI 1.11–1.81), and Asian/Pacific Islander (AOR 1.40, 95% CI 1.07–1.83) patients had significantly higher odds of SMM compared with White patients. Additional predictors included age ≥35 years (AOR 1.54, 95% CI 1.31–1.80), obesity (AOR 1.19, 95% CI 1.01–1.39), hypertension (AOR 1.65, 95% CI 1.32–2.04), and public insurance (AOR 1.35, 95% CI 1.14–1.60). Urban nonteaching hospitals (AOR 0.63, 95% CI 0.50–0.79) and Midwest hospital region (AOR 0.76, 95% CI 0.62–0.93) were associated with reduced odds of SMM. Conclusion: Racial disparities in SMM persisted among patients with PCOS despite adjustment for comorbidities and hospital factors. Race-conscious prenatal care and structural interventions are needed to reduce inequities.
- 16 February 2026
- Published by SAGE Publications in Journal of Women's Health
Racial Disparities in Severe Maternal Morbidity Among Patients with Polycystic Ovarian Syndrome
Objective: To evaluate the association between race and severe maternal morbidity (SMM) in delivery hospitalizations with polycystic ovarian syndrome (PCOS). Design: Retrospective cross-sectional study using the Nationwide Inpatient Sample (Q4 2015–2019). SMM was defined by the CDC algorithm of 21 ICD-10 indicators. Multivariable logistic regression assessed associations between race and SMM, adjusting for demographics, insurance, hospital type, obesity, hypertension, and diabetes. Subjects: Delivery hospitalizations with PCOS (ICD-10 E28.2). Results: Of 3.1 million deliveries, 19,962 (0.64%) had PCOS; 444 (2.22%) experienced SMM. Patients were predominantly White (66.7%) and <35 years (76.9%). Common comorbidities included obesity (30.2%), hypertension (9.5%), and diabetes (5.1%). Unadjusted analyses showed the highest SMM among Black (3.4%), Native American/Other (3.0%), and Asian/Pacific Islander (2.7%) patients. SMM was also more common among those ≥35 years, with public insurance, and at urban teaching hospitals. In adjusted models, Native American/Other (adjusted odds ratio [AOR] 1.44, 95% confidence interval [CI] 1.07–1.92), Black (AOR 1.42, 95% CI 1.11–1.81), and Asian/Pacific Islander (AOR 1.40, 95% CI 1.07–1.83) patients had significantly higher odds of SMM compared with White patients. Additional predictors included age ≥35 years (AOR 1.54, 95% CI 1.31–1.80), obesity (AOR 1.19, 95% CI 1.01–1.39), hypertension (AOR 1.65, 95% CI 1.32–2.04), and public insurance (AOR 1.35, 95% CI 1.14–1.60). Urban nonteaching hospitals (AOR 0.63, 95% CI 0.50–0.79) and Midwest hospital region (AOR 0.76, 95% CI 0.62–0.93) were associated with reduced odds of SMM. Conclusion: Racial disparities in SMM persisted among patients with PCOS despite adjustment for comorbidities and hospital factors. Race-conscious prenatal care and structural interventions are needed to reduce inequities.
- Open Access
- 15 December 2025
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 12 (2) , 102097
Case report of the management of intravascular leiomyomatosis including uterine surgery, vascular surgery, hormonal management, and in vitro fertilization
- 15 December 2025
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 12 (2) , 102097
Open AccessCase report of the management of intravascular leiomyomatosis including uterine surgery, vascular surgery, hormonal management, and in vitro fertilization